From bench to bedside – A mission for a healthy life
From bench to bedside – A mission for a healthy life
The DRFZ investigates the long‐term outcomes of rheumatic diseases, including the impact of current treatment options, in order to inform clinical decision making, identify unmet needs and improve health care. Biomedical research identifies the cells initiating and those driving rheumatic diseases, and the underlying molecular mechanisms. Our aim is the development of improved, personalised, at best curative therapies for patients with rheumatic diseases, and their rapid translation into clinical practice.
News
Science at DRFZ
Lisa Budzinski: Extending the analysis of the intestinal microbiome by single-cell based phenotyping
Xiaohui Liu: TLR1/2 stimulation metabolically regulates human chondrocytes
Jan Klocke: Chances and challenges of advanced urinalysis
Agata Konopka: The role of Oncostatin M in virus-induced lung inflammation
Mediathek
News | 21.November 2022
Mir-Farzin Mashreghi
...... is the new head of the Systems Rheumatology Research Department
News | 10. March 2022
Anja Strangfeld
... is the head of the Programme Area Epidemiology at the DRFZ
News | 02. November 2022
Carsten Watzl
... has been Chairman of the Scientific Advisory Board of the DRFZ since September 2022